Search

everythinglearnresearchcommunity

for

Search:↓

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Hydroxychloroquine effectively treated twenty-nail dystrophy in a patient with alopecia areata.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Umbilical cord-derived media is safe and effective for hair growth.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

New cytokine-targeted therapies show promise for treating alopecia areata.

Certain gene variations may increase the risk and severity of alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Oxidative stress is important in causing alopecia areata.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.